Cell replacement therapy is making massive strides for other diseases. But what about Huntington’s disease? Can we use ...

Proteins are like molecular dancers, with the cell acting as their dance floor. Proteins pair up with various partners to perform elaborate dances. Depending on who they partner with, they can carry ...

While HD primarily affects the brain, people with HD have subtle changes to their nervous system that can also affect heart rate and blood pressure. The scientists who worked on this paper had ...

AJ is an Instructor of Cell Biology at Columbia Basin College in Pasco, Washington. During his undergraduate studies at Western Washington University, AJ worked on HD in Dr. Jeff Carroll's lab. AJ ...

On December 10, 2024 we received a regulatory update from uniQure about their drug, AMT-130, that they’re advancing through the clinic for Huntington’s disease (HD). On the call, uniQure announced ...

Vico Therapeutics recently presented at several conferences to share an interim update on their Phase 1/2a clinical trial testing their drug called VO659, which targets the repeating C-A-Gs in people ...

On December 3, 2024 we received word that the very first person received a new drug, called ALN-HTT02, as part of a Phase 1 trial aiming to treat Huntington’s disease (HD). Going boldly as the first ...